Document Detail

Cytological effect of nogalamycin in mammals and regression of methylcholanthrene-induced and spontaneous tumors in rats.
MedLine Citation:
PMID:  977202     Owner:  NLM     Status:  MEDLINE    
The cytological effect of nogalamycin was studied in rats, mice and cultured human leukocytes. Four standard test systems were used: (1) Analysis of spermatogonial cells, (2) Cytological evaluation of bone-marrow metaphase plates, (3) micronucleus test in polychromatic erythrocytes, and (4) Determination of chromosomal aberrations in cultured human leukocytes. The results of the studies indicated that the types and frequencies of cytological errors induced by the drug were not significantly different from the concurrent controls. Chemically induced fibrosarcoma tumors and tumors of spontaneous origin in rats were successfully regressed following the administration of nogalamycin. Simultaneous transplantation of chemically induced fibrosarcoma tumors and intraperitoneal administration of nogalamycin, irreversibly inhibited growth of primary tumors in rats. The most effective concentration of nogalamycin for either regression of actively growing fibrosarcoma tumors or inhibition of transplanted fibrosarcoma cells was 556 mug/kg of body weight.
M A Bempong
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of clinical pharmacology and biopharmacy     Volume:  14     ISSN:  0340-0026     ISO Abbreviation:  Int J Clin Pharmacol Biopharm     Publication Date:  1976 Jul 
Date Detail:
Created Date:  1976-12-30     Completed Date:  1976-12-30     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7505527     Medline TA:  Int J Clin Pharmacol Biopharm     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  6-14     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chromosome Aberrations
Fibrosarcoma / drug therapy
Mice, Inbred C57BL
Naphthacenes / pharmacology*
Nogalamycin / pharmacology*
Sarcoma, Experimental / chemically induced,  drug therapy*
Reg. No./Substance:
0/Mutagens; 0/Naphthacenes; 1404-15-5/Nogalamycin; 56-49-5/Methylcholanthrene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Psychopharmacological studies on the interactions between alcohol and oxazepam with regard to reacti...
Next Document:  Photochemotherapy (PUVA) and psoriasis: comparison of 8-MOP and 8-MOP/5-MOP.